Atomistry » Arsenic » PDB 5hr7-5o4e » 5krt
Atomistry »
  Arsenic »
    PDB 5hr7-5o4e »
      5krt »

Arsenic in PDB 5krt: Hiv-1 Integrase Catalytic Core Domain (Ccd) in Complex with A Fragment-Derived Allosteric Inhibitor

Protein crystallography data

The structure of Hiv-1 Integrase Catalytic Core Domain (Ccd) in Complex with A Fragment-Derived Allosteric Inhibitor, PDB code: 5krt was solved by D.Patel, J.D.Bauman, E.Arnold, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 28.24 / 1.65
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 72.069, 72.069, 66.348, 90.00, 90.00, 120.00
R / Rfree (%) 18.5 / 19.5

Other elements in 5krt:

The structure of Hiv-1 Integrase Catalytic Core Domain (Ccd) in Complex with A Fragment-Derived Allosteric Inhibitor also contains other interesting chemical elements:

Chlorine (Cl) 4 atoms

Arsenic Binding Sites:

The binding sites of Arsenic atom in the Hiv-1 Integrase Catalytic Core Domain (Ccd) in Complex with A Fragment-Derived Allosteric Inhibitor (pdb code 5krt). This binding sites where shown within 5.0 Angstroms radius around Arsenic atom.
In total 2 binding sites of Arsenic where determined in the Hiv-1 Integrase Catalytic Core Domain (Ccd) in Complex with A Fragment-Derived Allosteric Inhibitor, PDB code: 5krt:
Jump to Arsenic binding site number: 1; 2;

Arsenic binding site 1 out of 2 in 5krt

Go back to Arsenic Binding Sites List in 5krt
Arsenic binding site 1 out of 2 in the Hiv-1 Integrase Catalytic Core Domain (Ccd) in Complex with A Fragment-Derived Allosteric Inhibitor


Mono view


Stereo pair view

A full contact list of Arsenic with other atoms in the As binding site number 1 of Hiv-1 Integrase Catalytic Core Domain (Ccd) in Complex with A Fragment-Derived Allosteric Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:As65

b:25.9
occ:1.00
AS A:CAF65 0.0 25.9 1.0
O1 A:CAF65 1.6 31.9 1.0
CE2 A:CAF65 2.0 30.4 1.0
CE1 A:CAF65 2.0 51.0 1.0
SG A:CAF65 2.2 20.4 1.0
HE23 A:CAF65 2.5 36.4 1.0
HE21 A:CAF65 2.5 36.4 1.0
HE22 A:CAF65 2.5 36.4 1.0
HE13 A:CAF65 2.5 61.2 1.0
HE11 A:CAF65 2.5 61.2 1.0
HE12 A:CAF65 2.5 61.2 1.0
HB2 A:CAF65 3.0 24.5 1.0
CB A:CAF65 3.2 20.4 1.0
HD21 A:ASN120 3.4 23.9 1.0
N A:CAF65 3.5 19.1 1.0
OD1 A:ASN120 3.5 28.5 1.0
ND2 A:ASN120 3.6 19.9 1.0
CG A:ASN120 3.7 24.6 1.0
HG2 A:GLU92 3.7 39.6 1.0
H A:CAF65 3.8 22.9 1.0
CA A:CAF65 3.9 18.7 1.0
HB3 A:CAF65 4.0 24.5 1.0
HD22 A:ASN120 4.0 23.9 1.0
HA A:ASP64 4.1 21.4 1.0
C A:ASP64 4.1 18.9 1.0
HG A:LEU74 4.1 37.6 1.0
CD A:GLU92 4.2 39.1 1.0
OE1 A:GLU92 4.2 50.5 1.0
HG1 A:THR97 4.2 25.5 1.0
HA A:CAF65 4.2 22.4 1.0
HB3 A:ASN120 4.3 28.8 1.0
CG A:GLU92 4.4 33.0 1.0
OG1 A:THR97 4.5 21.3 1.0
OE2 A:GLU92 4.5 38.4 1.0
CA A:ASP64 4.6 17.8 1.0
CB A:ASN120 4.6 24.0 1.0
O A:ASP64 4.8 21.4 1.0
HB3 A:GLU92 4.8 41.0 1.0
HD12 A:LEU74 4.8 38.0 1.0
O A:HOH450 4.9 35.8 1.0
O A:HOH411 5.0 32.3 1.0

Arsenic binding site 2 out of 2 in 5krt

Go back to Arsenic Binding Sites List in 5krt
Arsenic binding site 2 out of 2 in the Hiv-1 Integrase Catalytic Core Domain (Ccd) in Complex with A Fragment-Derived Allosteric Inhibitor


Mono view


Stereo pair view

A full contact list of Arsenic with other atoms in the As binding site number 2 of Hiv-1 Integrase Catalytic Core Domain (Ccd) in Complex with A Fragment-Derived Allosteric Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:As130

b:32.7
occ:1.00
AS A:CAF130 0.0 32.7 1.0
O1 A:CAF130 1.5 20.3 1.0
CE1 A:CAF130 1.9 39.3 1.0
CE2 A:CAF130 2.0 51.2 1.0
SG A:CAF130 2.2 16.9 1.0
HE11 A:CAF130 2.4 47.1 1.0
HE13 A:CAF130 2.4 47.1 1.0
HE12 A:CAF130 2.4 47.1 1.0
HE23 A:CAF130 2.5 61.4 1.0
HE22 A:CAF130 2.5 61.4 1.0
HE21 A:CAF130 2.5 61.4 1.0
HB2 A:CAF130 3.1 22.4 1.0
CB A:CAF130 3.1 18.7 1.0
HB3 A:CAF130 3.2 22.4 1.0
HG21 A:VAL113 3.4 50.3 1.0
HG22 A:VAL113 3.6 50.3 1.0
HG22 A:ILE135 3.7 22.3 1.0
CG2 A:VAL113 3.8 41.9 1.0
HG23 A:VAL113 3.8 50.3 1.0
HG12 A:VAL126 4.0 21.6 1.0
HG21 A:ILE135 4.2 22.3 1.0
HB A:ILE135 4.2 21.7 1.0
CG2 A:ILE135 4.3 18.6 1.0
O A:ILE135 4.4 23.5 1.0
HD13 A:LEU101 4.4 24.6 1.0
HA A:CAF130 4.4 22.8 1.0
HB3 A:PHE121 4.4 27.7 1.0
HB2 A:GLN137 4.4 51.2 1.0
HA A:GLN137 4.5 38.9 1.0
CA A:CAF130 4.6 19.0 1.0
HG13 A:VAL126 4.6 21.6 1.0
CG1 A:VAL126 4.7 18.0 1.0
HA A:LYS127 4.7 20.6 1.0
C A:LYS136 4.8 27.6 1.0
N A:GLN137 4.8 28.9 1.0
O A:LYS136 4.8 26.9 1.0
HG11 A:VAL126 4.8 21.6 1.0
CB A:ILE135 4.8 18.1 1.0
HA A:LYS136 4.8 32.6 1.0
C A:ILE135 4.9 22.5 1.0
H A:CAF130 4.9 18.9 1.0
HD11 A:LEU101 4.9 24.6 1.0
CD2 A:PHE121 4.9 28.9 1.0
OE1 A:GLN137 4.9 48.5 1.0
O A:VAL126 5.0 15.7 1.0
CG A:PHE121 5.0 22.6 1.0
H A:GLN137 5.0 34.7 1.0
CA A:GLN137 5.0 32.4 1.0

Reference:

D.Patel, J.Antwi, P.C.Koneru, E.Serrao, S.Forli, J.J.Kessl, L.Feng, N.Deng, R.M.Levy, J.R.Fuchs, A.J.Olson, A.N.Engelman, J.D.Bauman, M.Kvaratskhelia, E.Arnold. A New Class of Allosteric Hiv-1 Integrase Inhibitors Identified By Crystallographic Fragment Screening of the Catalytic Core Domain. J.Biol.Chem. V. 291 23569 2016.
ISSN: ESSN 1083-351X
PubMed: 27645997
DOI: 10.1074/JBC.M116.753384
Page generated: Sat Dec 12 01:47:00 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy